NCT03417830 Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging Status TERMINATED Phase PHASE1
NCT03415243 To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT03409107 Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) Status COMPLETED Phase PHASE3
NCT03408678 Determinants of Type 2 Diabetes Risk in Middle-aged Black South African Men and Women Status COMPLETED Phase N/A
NCT03408392 Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT03404960 Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT03400033 Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) Status COMPLETED Phase PHASE3
NCT03399461 Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS) Status COMPLETED Phase N/A
NCT03398421 A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib Status COMPLETED Phase PHASE1
NCT03393806 Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD) Status TERMINATED Phase PHASE2
NCT03383783 Evaluation of the Fluoride Dose Response of a Modified In Situ Caries Model Status COMPLETED Phase PHASE3
NCT03380429 A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects Status COMPLETED Phase PHASE4
NCT03376932 Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma Status WITHDRAWN Phase PHASE3
NCT03372603 A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough Status TERMINATED Phase PHASE1/PHASE2
NCT03368053 Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) Status COMPLETED Phase PHASE1
NCT03363191 The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma Status WITHDRAWN Phase PHASE4
NCT03361774 A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity Status WITHDRAWN Phase PHASE2
NCT03359473 Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2